Leah R Neufeld insider trades: Immuneering (IMRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Leah reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | IMRX | ↑ Buy | 2,626 | $4.15 | $11K | Direct | Jan 15, 2026 (2d) |
| Oct 1, 2025 | IMRX | ↑ Buy | 800 | $6.38 | $5K | Direct | Oct 2, 2025 (1d) |
| Jul 2, 2025 | IMRX | ↑ Buy | 700 | $3.57 | $2K | Direct | Jul 7, 2025 (5d) |
| Mar 20, 2024 | IMRX | ↑ Buy | 3,818 | $2.88 | $11K | Direct | Mar 21, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMRX insiders
Open-market trades in the last 12 months
About Leah R Neufeld's insider trades
Leah R Neufeld is Chief People Officer at Immuneering (IMRX). Since Mar 20, 2024, Leah has reported 4 open-market purchases worth $30K and no sales on SEC Form 4. In the last 12 months: 1 buy ($11K).
Their filings also include grants and awards (9 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.